Total Payments
$17,955
2023 Payments
$248.99
Companies
45
Transactions
501
Medicare Patients
531
Medicare Billing
$53,450
Payment Breakdown by Category
Food & Beverage$16,807 (93.6%)
Other$1,120 (6.2%)
Education$28.43 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,807 | 494 | 93.6% |
| Debt forgiveness | $1,120 | 1 | 6.2% |
| Education | $28.43 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,710 | 53 | $0 (2022) |
| Amgen Inc. | $1,902 | 33 | $0 (2022) |
| Novo Nordisk Inc | $1,541 | 48 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $1,276 | 80 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $1,183 | 42 | $0 (2022) |
| Beckman Coulter, Inc. | $1,120 | 1 | $0 (2022) |
| AbbVie Inc. | $892.95 | 18 | $0 (2021) |
| Allergan, Inc. | $844.58 | 17 | $0 (2020) |
| ITI, Inc. | $768.92 | 22 | $0 (2023) |
| Lilly USA, LLC | $700.18 | 16 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $248.99 | 5 | ITI, Inc. ($202.13) |
| 2022 | $2,405 | 53 | Beckman Coulter, Inc. ($1,120) |
| 2021 | $3,454 | 83 | AstraZeneca Pharmaceuticals LP ($678.21) |
| 2020 | $1,112 | 31 | AstraZeneca Pharmaceuticals LP ($236.75) |
| 2019 | $3,523 | 83 | Amgen Inc. ($742.51) |
| 2018 | $3,363 | 111 | AstraZeneca Pharmaceuticals LP ($405.50) |
| 2017 | $3,848 | 135 | AstraZeneca Pharmaceuticals LP ($757.14) |
All Payment Transactions
501 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/28/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: PSYCHIATRY | ||||||
| 04/11/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $46.86 | General |
| Category: Obesity | ||||||
| 03/28/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $79.50 | General |
| Category: PSYCHIATRY | ||||||
| 02/03/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: PSYCHIATRY | ||||||
| 01/12/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $98.32 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 11/03/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 10/26/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $9.63 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 09/30/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 09/23/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 09/09/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 08/29/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Diabetes | ||||||
| 08/26/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 08/19/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 08/05/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 07/29/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 06/17/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 06/10/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 06/09/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.23 | General |
| Category: PSYCHIATRY | ||||||
| 06/03/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 05/27/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 05/20/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 05/17/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Diabetes | ||||||
| 05/13/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 10 | 348 | 687 | $113,810 | $34,835 |
| 2020 | 7 | 183 | 283 | $49,573 | $18,614 |
Total Patients
531
Total Services
970
Medicare Billing
$53,450
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 125 | $39,844 | $10,932 | 27.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 53 | 118 | $28,982 | $6,775 | 23.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 26 | 40 | $15,094 | $5,308 | 35.2% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2021 | 56 | 71 | $7,100 | $3,643 | 51.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 55 | 69 | $8,625 | $3,540 | 41.0% |
| 20552 | Injections of trigger points in 1 or 2 muscles | Office | 2021 | 36 | 56 | $5,042 | $2,133 | 42.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 21 | 21 | $6,012 | $1,259 | 20.9% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 12 | 20 | $1,000 | $712.03 | 71.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 22 | 55 | $1,153 | $496.72 | 43.1% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2021 | 18 | 112 | $960.00 | $35.85 | 3.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 37 | 77 | $14,292 | $6,164 | 43.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 48 | 103 | $15,043 | $5,846 | 38.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 40 | 40 | $11,064 | $3,009 | 27.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $2,752 | $1,394 | 50.6% |
| 87635 | Sars-cov-2 covid-19 amp prb | Office | 2020 | 15 | 15 | $1,875 | $769.65 | 41.0% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2020 | 15 | 15 | $1,550 | $769.65 | 49.7% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 17 | 22 | $2,997 | $662.06 | 22.1% |
About Dr. Ibrahim Oudeh, MD
Dr. Ibrahim Oudeh, MD is a Internal Medicine healthcare provider based in Dunn, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538240437.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ibrahim Oudeh, MD has received a total of $17,955 in payments from pharmaceutical and medical device companies, with $248.99 received in 2023. These payments were reported across 501 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($16,807).
As a Medicare-enrolled provider, Oudeh has provided services to 531 Medicare beneficiaries, totaling 970 services with total Medicare billing of $53,450. Data is available for 2 years (2020–2021), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Dunn, NC
- Active Since 10/18/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1538240437
Products in Payments
- ACCESS 2 (Device) $1,120
- FARXIGA (Drug) $993.57
- Ozempic (Drug) $851.14
- Aimovig (Biological) $839.25
- VRAYLAR (Drug) $817.21
- CAPLYTA (Drug) $768.92
- ENTRESTO (Drug) $652.16
- XARELTO (Drug) $629.74
- Nuedexta (Drug) $601.87
- NUEDEXTA (Drug) $572.23
- Repatha (Biological) $556.73
- INVOKANA (Drug) $547.05
- TRULICITY (Drug) $516.26
- NEXLIZET (Drug) $477.43
- BREZTRI (Drug) $431.75
- JARDIANCE (Drug) $424.48
- BEVESPI AEROSPHERE (Drug) $411.94
- ELIQUIS (Drug) $358.19
- LOKELMA (Drug) $325.33
- Prolia (Biological) $285.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Dunn
Dr. Josette Maria, Md, MD
Internal Medicine — Payments: $15,921
Internal Medicine $15,921
Dr. Radhakrishnan Ramaraj, Md, MD
Internal Medicine — Payments: $11,028
Internal Medicine $11,028
Varun Bavyer, M.d, M.D
Internal Medicine — Payments: $2,993
Internal Medicine $2,993
Dr. Shantanu Singh, M.d, M.D
Internal Medicine — Payments: $619.41
Internal Medicine $619.41
Michelle Scribner, Do, DO
Internal Medicine — Payments: $324.20
Internal Medicine $324.20
Dr. James Cappola, M.d, M.D
Internal Medicine — Payments: $112.18
Internal Medicine $112.18